SEC Tracker
Get the app

Calidi Biotherapeutics CLDI

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Reports quarterly results (2.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Calidi Biotherapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. In8bio INAB public float $8M, Jun 30, 2025
  2. VivoSim Labs VIVS public float $8M, Sep 30, 2025
  3. Intensity Therapeutics INTS public float $7M, Jun 30, 2025
  4. Zeo ScientifiX ZEOX public float $7M, Apr 30, 2025, over 18 months old
  5. Abpro Holdings ABP public float $9M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.